Full Press Release Details
Supplied medicines to approximately 1 billion patients globally
PITTSBURGH , May 16, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS ), a global healthcare company, today published its 2022 Sustainability Report showcasing its commitment, impact and progress on building sustainable access to medicine as it continues to make a positive difference across key areas including Access and Global Health, Our People, the Environment and the Community.
Viatris supplied medicines to approximately 1 billion patients globally in 2022
"At Viatris, access is fundamental to our mission of empowering people worldwide to live healthier at every stage of life," said Scott A. Smith , CEO, Viatris. "It begins with our ability to sustainably deliver high-quality medicines and health solutions at scale to people, regardless of geography or circumstance. Our commitment is both practical and aspirational and goes beyond developing, making and distributing medicines. We also work with partners to help support healthy communities, a healthy environment and resilient healthcare systems. The passion and dedication of our global workforce is remarkable and clearly on display in this report, which highlights the progress we are making to build more sustainable access to medicine across the globe."
Viatris is a signatory to the United Nations Global Compact (UNGC) and is committed to the Compact's 10 principles related to human rights, labor, the environment and anti-corruption and supports the Sustainable Development Goals.
The following are some highlights of Viatris' work and initiatives across its multiple areas of impact in 2022:
Access and Global Health
The Environment
"We understand our conduct and actions affect the stakeholders and communities we serve," said Lara Ramsburg , Head of Corporate Affairs of Viatris. "We are proud to continue our work as a trusted partner of key stakeholders as we help to close gaps to equal access to care, build more resilient healthcare systems, uphold a reliable global supply of medicines, curb climate change and protect the environment."
Viatris is dedicated to transparent annual reporting on environmental, social and governance matters, continuously working to further enhance its disclosures. Click here to view more information or to read our 2022 Sustainability Report.
About Viatris Viatris Inc. (NASDAQ: VTRS ) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020 , Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines and a variety of over-the-counter consumer products. With more than 38,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh , Shanghai and Hyderabad, India . Learn more at viatris.com and investor.viatris.com , and connect with us on Twitter at @ViatrisInc , LinkedIn , Instagram and YouTube .